The COVID-19 pandemic has brought to the fore the importance of faster methods of drug discovery and development. New variants of disease-causing pathogens can wreak immeasurable havoc before the discovery…
GBSI is a LutinX project developed under the “EdVerso International” guide. We work worldwide to promote standard qualification schemes and intellectual property awareness. LutinX is active in the USA, Canada, Mexico, Switzerland, Italy, Ireland, Norway, Germany, Spain, Portugal, Ukraine, Senegal, Guinea, Sierra Leone, Liberia, Ghana, the Gambia, Nigeria, Kenya, India, and Pakistan.